TARGETING CD46 FOR BOTH ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER СтатьяSu Y., Liu Y., Behrens C.R., Bidlingmaier S., Lee N.K., Liu B., Aggarwal R., Sherbenou D.W., Shuman M.A., Small E.J., Hann B.C., Simko J.P., Premasekharan G., Paris P.L., Burlingame A.L., Seo Y.JCI Insight. Том 3. 2018.
